N43CO130030-007 (N43) | |||
---|---|---|---|
Title | EGFR-targeted siRNA nanoparticles to treat NSCLC | ||
Institution | GENESEGUES INC, CHASKA, MN | ||
Principal Investigator | UNGER, GRETCHEN | NCI Program Director | |
Cancer Activity | Division | ||
Funded Amount | $1,000,000 | Project Dates | 09/20/2013 - 05/29/2015 |
Fiscal Year | 2014 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) Gene Therapy (100.0%) |
Lung (100.0%) | ||
Research Type | |||
Resources and Infrastructure Related to Treatment and the Prevention of Recurrence | |||
Abstract | |||
No abstract available. |